Showing 1 - 5 results of 5 for search 'Michael D Bobardt', 查询时间: 0.02s Refine Results
  1. 1
    Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175.

    Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175. 由 Philippe A Gallay, Udayan Chatterji, Michael D Bobardt, Zhengyu Long, Shengli Zhang, Zhuang Su

    出版 2016-01-01
    获取全文
    文件
  2. 2
    HCV core residues critical for infectivity are also involved in core-NS5A complex formation.

    HCV core residues critical for infectivity are also involved in core-NS5A complex formation. 由 Katarzyna Gawlik, James Baugh, Udayan Chatterji, Precious J Lim, Michael D Bobardt, Philippe A Gallay

    出版 2014-01-01
    获取全文
    文件
  3. 3
    Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms

    Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms 由 Brigitte Rosenwirth, Jean-Maurice Dumont, Grégoire Vuagniaux, Michael D. Bobardt, Philippe A. Gallay, Roger G. Ptak

    出版 2013-03-01
    获取全文
    文件
  4. 4
    Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice

    Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice 由 Jeremy R. A. Paull, Carolyn A. Luscombe, Alex Castellarnau, Graham P. Heery, Michael D. Bobardt, Philippe A. Gallay

    出版 2021-08-01
    获取全文
    文件
  5. 5
    Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium

    Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium 由 Jeremy R. A. Paull, Carolyn A. Luscombe, Aynaz Seta, Graham P. Heery, Michael D. Bobardt, Philippe A. Gallay, Samuel Constant, Alex Castellarnau

    出版 2024-09-01
    获取全文
    文件

检索工具: